Health
BIOCAD to produce liquid vaccine for COVID-19 treatment – News-Medical.Net
Clinical trials of the vaccine are currently underway. The «Sputnik V» is the two-component vaccine. Revaccination is carried out at intervals of 3-4 weeks. Moreover, with the repeated introduction of a particle of coronavirus RNA, it is covered with a n…
Reviewed by Emily Henderson, B.Sc.Sep 25 2020
Clinical trials of the vaccine are currently underway. The «Sputnik V» is the two-component vaccine. Revaccination is carried out at intervals of 3-4 weeks. Moreover, with the repeated introduction of a particle of coronavirus RNA, it is covered with a new adenovirus.
This is done in order to exclude the presence of neutralizing antibodies against the vaccine in humans and thus enhance the reliability of repeated injection. The article on …
-
Noosa News24 hours agoWorking for someone else made it hard to care for my daughter. So I quit
-
Noosa News6 hours agoHow Lily Steele-Park took her rapist to court and won
-
General20 hours ago‘Potential’ hacker contacts Qantas over data breach
-
Business11 hours agoFord CEO makes stunning prediction about artificial intelligence